BNALTD vs INDOUS: Stock Comparison
B & A Ltd vs Indo Us Biotech Limited
Live data: 21 July 2026, 4:08 PM IST • Source: NSE and company filings
Indo Us Biotech Limited is the larger company by market capitalisation. B & A Ltd shows faster revenue growth, while Indo Us Biotech Limited shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of B & A Ltd and Indo Us Biotech Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BNALTD | INDOUS |
|---|---|---|
| Sector | — | Fast Moving Consumer Goods |
| Industry | — | Other Agricultural Products |
Price
| Metric | BNALTD | INDOUS |
|---|---|---|
| Live Price | ₹519.55 | ₹84.98 |
| Day Change | -1.41% | -2.24% |
| Volume | 879 | 17,311 |
| 52-Week High | ₹589 | ₹182.1 |
| 52-Week Low | ₹310.4 | ₹84.91 |
| Distance from 52W High | -11.79% | -53.33% |
Valuation
| Metric | BNALTD | INDOUS |
|---|---|---|
| Market Cap | ₹144 Cr | ₹170 Cr |
| P/E Ratio | — | 0x |
| P/B Ratio | — | 0x |
| EPS | ₹-12.7 | ₹6.54 |
| Book Value | ₹442 | ₹45.99 |
| Dividend Yield | 0% | 0.29% |
Growth
| Metric | BNALTD | INDOUS |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | -22% |
| EPS Growth (TTM YoY) | 0% | -47.3% |
| Qtr Sales Growth | 1.63% | 5.64% |
| Qtr Profit Growth | -86% | -24% |
Profitability & Leverage
| Metric | BNALTD | INDOUS |
|---|---|---|
| ROE | -2.83% | 16.9% |
| ROCE | 3.77% | 15.4% |
| Net Margin | -0.68% | 11.88% |
| Operating Margin | 4.05% | 13.8% |
| Debt to Equity | 0.81x | 0.33x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | BNALTD | INDOUS |
|---|---|---|
| Promoter Holding | 59.47% | 68.29% |
| FII Holding | — | 0.01%▼ 0.17 pp |
| DII Holding | 0.01% | — |
| Public Holding | 40.52% | 31.7%▲ 0.17 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: B & A Ltd and Indo Us Biotech Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.